Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.08M P/E - EPS this Y 45.20% Ern Qtrly Grth -
Income -8.36M Forward P/E - EPS next Y 5.90% 50D Avg Chg -40.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -48.00%
Dividend N/A Price/Book 2.45 EPS next 5Y - 52W High Chg -87.00%
Recommedations 2.00 Quick Ratio 10.16 Shares Outstanding 16.01M 52W Low Chg 4.00%
Insider Own 46.72% ROA -102.62% Shares Float 8.02M Beta -
Inst Own 3.45% ROE -780.59% Shares Shorted/Prior 173.70K/21.91K Price 0.85
Gross Margin - Profit Margin - Avg. Volume 390,282 Target Price 3.50
Oper. Margin - Earnings Date - Volume 53,124 Change -2.31%
About Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Cadrenal Therapeutics, Inc. News
04/20/24 Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock
04/11/24 Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
04/09/24 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
03/11/24 Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update
02/26/24 Cadrenal Therapeutics to Participate at Technology and Heart Failure Therapeutics (THT) Conference
02/08/24 Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating Officer in Advance of Tecarfarin Phase 3 Pivotal Trial
01/31/24 Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
01/30/24 Here's Why We're Not Too Worried About Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Situation
01/24/24 Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
01/04/24 Cadrenal Therapeutics to Present at the Biotech Showcase on January 8, 2024 Alongside the J.P. Morgan Annual Healthcare Conference
12/19/23 Noble Capital Markets Initiates Coverage on Cadrenal Therapeutics with Outperform Rating and US$4.00 Price Target
12/12/23 Cadrenal Therapeutics Engages The Sage Group to Advance Tecarfarin's Late-Stage Development and Commercialization
11/30/23 Cadrenal Therapeutics to Present at the NobleCon 19 Conference on December 4, 2023
11/09/23 Cadrenal Therapeutics Provides Third Quarter 2023 Corporate Update
10/09/23 Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference
09/05/23 Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress
08/30/23 Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
08/28/23 Cadrenal Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
08/10/23 Cadrenal Therapeutics Provides Second Quarter 2023 Corporate Update
08/01/23 Cadrenal Therapeutics Expands Focus for Tecarfarin to Patients with Implanted Medical Devices for Heart Diseases
CVKD Chatroom

User Image Cashcowtipper Posted - 7 hours ago

$CVKD watchers at all time high..any day now and I have decades I’ll wait if need be not a care in the world!

User Image RiseAndRiseAgain Posted - 12 hours ago

$CVKD this is itching to blow.

User Image Harleybug Posted - 16 hours ago

$CVKD i'm gonna make so much money shorting this shit outta this !

User Image BHWinehouse Posted - 17 hours ago

$CVKD I just added. I'm happy to hold and watch them bring Tecarfarin to market or entertain a nice buyout offer, either way, I'm here for a while.

User Image hichemben Posted - 18 hours ago

$CVKD 🙌🏻🚀

User Image Cashcowtipper Posted - 19 hours ago

$CVKD

User Image makedatbread88 Posted - 04/30/24

$CVKD and $ENSC are two cheap bios near lows here to watch

User Image The_Claw Posted - 04/30/24

$CVKD I like this game and I’m in no rush. This one will have its day.

User Image Cashcowtipper Posted - 04/29/24

$CVKD almost 200k volume today…life!?

User Image MCapitalJ Posted - 04/29/24

$CVKD 👀🤔

User Image Car_key Posted - 04/29/24

$CVKD Volume moving in

User Image KPbullish Posted - 04/29/24

$CVKD will it fill my order at .4250 plz

User Image Dazkusmoney Posted - 04/29/24

$CVKD MM’s in full control here and holding it down. Retail doesn’t have a chance until they either let it run or we get some big news. Just my opinion. We need a partnership announcement ASAP!

User Image Bartos1976 Posted - 04/27/24

$CVKD had a dream recently that Tecarfrin success was covered widely across international media and the price went nuts making me ridiculously rich in an instant. Well, might not happen quite like that but this drug will certainly be a success and be big news in the world of medicine

User Image RiseAndRiseAgain Posted - 04/26/24

$CVKD can’t wait for this to get back to dollar land.

User Image Shmafe Posted - 04/26/24

$CVKD Crazy this is around ATL’s with all the favorable news this month…

User Image Harleybug Posted - 04/25/24

$CVKD this stock is dead !

User Image Orca_Bait Posted - 04/24/24

$CVKD keep developing that base level support

User Image TrojanTradez Posted - 04/24/24

$CVKD When is approval expected?

User Image Cashcowtipper Posted - 04/23/24

$CVKD after approval

User Image Behzat Posted - 04/23/24

$CVKD

User Image Cashcowtipper Posted - 04/22/24

$CVKD

User Image MegaTrade22 Posted - 04/22/24

$CVKD Anyone adding in this levels? Looking for Re-entry! This one paid over 100% last time

User Image Alertingstocks Posted - 04/21/24

$FRGT $CVKD $KSCP THese 3 are heading into A+ buy zones! Also watch ticker GBR GBR top trending on watchers Cash+No dilution + clean low floaters with bull cross happening on the weekly $7++ potential

User Image Orca_Bait Posted - 04/21/24

$CVKD I like the stock 🦭🐱

User Image Scientwist Posted - 04/21/24

$CVKD FDA Orphan Drug Designation for tecarfarin and insider buying highlight confidence and potential in #CadrenalTherapeutics. Strong bullish signals for #CVKD. #Biotech

User Image Harleybug Posted - 04/20/24

$CVKD i keep posting tht this stock sucks , but its looking like this could be acquired or partnered with somone soon , these levels im loading up , look what happened with grrr.

User Image Harleybug Posted - 04/19/24

$CVKD 💩

User Image BichonBegone Posted - 04/19/24

$ICU If this stock somehow dips below $CVKD price I will laugh so hard that the only thing going to the moon is my ass.

User Image BHWinehouse Posted - 04/19/24

$CVKD Quang mentions "partnership" several times. I see this more and more as a buyout candidate.

Analyst Ratings
HC Wainwright & Co. Buy Mar 14, 24
Noble Capital Markets Outperform Dec 18, 23
HC Wainwright & Co. Buy Nov 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
MURPHY JOHN RAYMOND Director Director Oct 04 Buy 0.7 20,000 14,000 614,792 10/06/23
Pham Quang X CEO and Chairman CEO and Chairman Sep 05 Buy 0.9 40,000 36,000 3,410,000 09/06/23
Pham Quang X CEO and Chairman CEO and Chairman Sep 01 Buy 0.91 70,000 63,700 3,370,000 09/05/23
MURPHY JOHN RAYMOND Director Director Mar 16 Buy 1.6699 20,000 33,398 574,792 03/16/23